Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2016-09-27 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于签订募集资金专户存储四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 金宇生物技术股份有限公司 regarding the signing of a four-party supervision agreement for the special account storage of raised funds. It details the amount of funds raised through a non-public stock issuance, the opening of a special account for these funds, and the regulatory compliance and supervision arrangements involving the company, its subsidiary, the bank, and the sponsor. The document does not contain financial statements or detailed financial performance data but rather focuses on the management and regulatory oversight of the raised capital. The length is 2733 characters, which is relatively short and the content is an announcement about the signing of an agreement related to capital raising and fund management. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or audit report. Therefore, the appropriate classification is CAP with high confidence.
2016-09-27 Chinese
公司章程（2016年9月修订稿）
Governance Information Classification · 95% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 金宇生物技术股份有限公司 (Jinyu Bio-Technology Co., Ltd.). It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, shareholder meetings, voting procedures, and other governance matters. The content is focused on the internal rules and governance framework of the company rather than financial results, audit opinions, or announcements. There is no indication that this is an annual report, audit report, earnings release, or any other financial or regulatory filing. Instead, it is a governance document that sets out the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2016-09-23 Chinese
第九届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 金宇生物技术股份有限公司 (Jinyu Biotechnology Co., Ltd.). It details decisions such as the establishment of a special account for raised funds, capital increase in a subsidiary using raised funds, use of raised funds to replace self-raised funds, amendments to the company charter, and cash management of idle funds. The document includes voting results and references to regulatory compliance and independent opinions. It is not a full financial report, earnings release, or audit report, but rather a disclosure of board decisions and corporate governance matters. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management. The document length is 1766 characters, which is relatively short and consistent with a board resolution announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2016-09-23 Chinese
关于第一大股东股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding the release of pledged shares by the company's largest shareholder. It contains specific details about shareholding and pledge status but does not include financial statements, management discussion, or other report content. The document length is only 538 characters, indicating it is a brief regulatory announcement. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or pledge status.
2016-09-23 Chinese
第九届监事会第三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of a company regarding decisions on the use of raised funds and cash management. It includes voting results and compliance statements but does not contain financial statements or detailed financial performance data. It is a formal announcement of board decisions rather than a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2016-09-23 Chinese
关于修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company regarding the revision of its Articles of Association (公司章程) due to a non-public issuance of shares approved by the China Securities Regulatory Commission. It details the increase in registered capital and total shares outstanding. The document is short (623 characters) and focuses on corporate governance changes related to capital structure, specifically the amendment of the company's charter to reflect new share issuance. This fits the category of Share Issue/Capital Change (SHA) because it announces changes in share capital and company registration details. It is not a full financial report, audit, or management report, nor is it a simple announcement of a report publication. Therefore, the correct classification is SHA with high confidence.
2016-09-23 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.